![Expert Consensus Recommendations on Biomarker Testing in Metastatic and Non metastatic NSCLC in Asia unnamed 1 1 unnamed 1 1](https://clinicalvalue.com/wp-content/uploads/2023/04/unnamed-1-1.jpg)
19 May 2023
Expert Consensus Recommendations on Biomarker Testing in Metastatic and Non metastatic NSCLC in Asia
This report provides consensus recommendations for NSCLC biomarker testing from Asian lung cancer experts for clinicians working in Asia to improve patient care. Biomarker testing approaches…
READ MORE